Randomized Angiographic Trial of Recombinant Tissue-Type Plasminogen Activator (Alteplase) in Myocardial Infarction - RAAMI

Description:

RAAMI was a multicenter, randomized, open-label trial of rt-PA 100 mg given over three hours versus rt-PA given over 90 minutes in patients with ST elevation myocardial infarction (STEMI).